166.1231 (Mϩ ϩ H. C10H16NO requires 166.1232), 165 (Mϩ,
50%), 124 (100).
(CH), 52.5 (CH2), 38.8 (CH2), 32.8 (CH2), 30.1 (CH2), 29.1
(CH2), 22.2 (CH2); m/z (EI) 179.1316 (Mϩ. C11H17NO requires
179.1310), 180 (Mϩ ϩ H, 3%), 138 (53).
(3S*,8aS*)-3-Allylhexahydroindolizin-2(3H)-one 19a and
(3R*,8aS*)-3-allylhexahydroindolizin-2(3H)-one 19b. Accord-
ing to the general procedure, a solution of the α-diazo ketone 8
(198 mg, 0.955 mmol) in dry benzene (95 cm3) was added to a
solution of Cu(acac)2 (5.1 mg, 0.019 mmol) in dry benzene
(5 cm3) at reflux, over a period of 2 h. The resulting solution
was stirred at reflux for a further 10 min. Analysis of the crude
reaction mixture by 1H NMR indicated exclusive formation
of indolizidinone 19a. Purification by flash column chrom-
atography on silica gel (hexane–diethyl ether, 2 : 1) gave the
indolizidinone 19a (83.7 mg, 49%) and the indolizidinone 19b
(21.8 mg, 13%), resulting from partial epimerisation during
chromatography, as colourless liquids (combined yield of 62%).
Data for 19a; νmax(film)/cmϪ1 3077, 2932, 2854, 2801, 1755,
4-Allyloctahydroquinolizin-3-one 21a and 21b. According
to the general procedure, a solution of the α-diazo ketone 17
(0.14 g, 0.63 mmol) in dry benzene (50 cm3) was added to a
solution of Cu(acac)2 (3.3 mg, 0.013 mmol) in dry benzene
(10 cm3) at reflux, over a period of 30 min. The resulting
solution was stirred at reflux for a further 15 min. Purification
by flash column chromatography on neutral alumina (hexane–
diethyl ether, 4 : 1) gave the quinolizidinone 21a–b major (64 mg,
52%) and minor (11 mg, 9%) isomers as colourless liquids.
Major isomer; νmax(film)/cmϪ1 2936, 2860, 2790, 2733, 1716,
1639, 995, 908; δH (400 MHz, CDCl3) 5.67 (1H, dddd, J 16.7,
10.2, 8.0 and 6.6, CH᎐CH ), 5.30–5.00 (2H, m, CH᎐CH ), 3.25
᎐
᎐
2
2
(1H, dd, J 9.7 and 5.5, NCHCO), 2.86–2.79 (1H, m, NCH-
CH CH ), 2.68–2.59 (3H, m, NCH and 1 × CH CH᎐CH ),
1640, 997, 914; δH (250 MHz, CDCl ) 5.90–5.83 (1H, m, CH᎐
᎐
᎐
3
2
2
2
2
2
CH ), 5.14–5.04 (2H, m, CH᎐CH ), 3.36 (1H, t, J 5.7,
2.48–2.32 (3H, m, CH CO and 1 × CH CH᎐CH ), 1.97–
᎐
2 2 2
᎐
2
2
NCHCO), 3.25–3.14 (1H, m, NCHCH2CO), 3.13–3.03 (1H, m,
1 × NCH2), 2.77 (1H, ddd, J 12.6, 11.2 and 3.8, 1 × NCH2),
1.91 (1H, m, 1 × NCHCH2CH2CO), 1.75–1.22 (7H, m, 1 ×
NCHCH2CH2CO, NCHCH2CH2, NCH2CH2CH2 and NCH2-
CH2CH2); δC (125 MHz, CDCl3) 209.2 (CO), 134.2 (CH), 117.1
(CH2), 72.2 (CH), 51.9 (CH), 51.2 (CH2), 36.5 (CH2), 33.0
(CH2), 31.9 (CH2), 29.2 (CH2), 25.7 (CH2), 23.7 (CH2); m/z (EI)
152.1080 (Mϩ Ϫ C3H5. C9H14NO requires 152.1075). Minor
isomer; νmax(film)/cmϪ1 3083, 2942, 2880, 2798, 2740, 2710,
1716, 1640, 995, 913; δH (400 MHz, CDCl3) 5.85 (1H, dddd,
J 17.2, 10.2, 6.9 and 6.9, CH᎐CH ), 5.10 (1H, dd, J 17.2 and
2.56–2.21 (3H, m, 1 × CH CO and CH CH᎐CH ), 2.09 (1H,
᎐
2
2
2
dd, J 18.0 and 5.6, 1 × CH2CO), 1.88–1.80 (1H, m, 1 × NCH2-
CH2CH2), 1.68–1.17 (5H, m, NCH2CH2, NCHCH2CH2 and
1 × NCH2CH2CH2); δC (67.8 MHz, CDCl3) 215.8 (CO), 134.7
(CH), 117.3 (CH2), 64.8 (CH), 56.3 (CH), 46.6 (CH2), 44.2
(CH2), 32.0 (CH2), 29.7 (CH2), 24.2 (CH2), 21.7 (CH2). Data
for 19b; νmax(CHCl3)/cmϪ1 2940, 2787, 1753, 994, 916; δH
(250 MHz, CDCl3) 5.81 (1H, m, dddd, J 17.1, 10.2, 7.2 and 6.2,
᎐
2
1.6, trans CH᎐CH ), 5.05 (1H, br d, J 10.2, cis CH᎐CH ), 3.20–
᎐
᎐
2
2
CH᎐CH ), 5.12–4.99 (2H, m, CH᎐CH ), 3.19 (1H, dt, J 10.8
3.15 (1H, m, 1 × NCH2), 2.76 (1H, dd, J 5.3 and 3.0, NCHCO),
2.68–2.61 (1H, m, 1 × CH CH᎐CH ), 2.60–2.49 (2H, m, 1 ×
᎐
᎐
2
2
and 2.7, 1 × NCH2), 2.51–2.27 (5H, m, NCHCH2CO, NCHCO,
CH CH᎐CH , and 1 × CH CO), 2.11–1.60 (6H, m, 1 × NCH ,
᎐
2
2
NCH and 1 × CH CH᎐CH ), 2.40–2.30 (2H, m, 1 × NCH-
᎐
᎐
2
2
2
2
2
2
2
1 × CH2CO, NCH2CH2, 1 × NCHCH2CH2 and 1 × NCH2-
CH2CH2), 1.47–1.32 (2H, m, 1 × NCHCH2CH2 and 1 ×
NCH2CH2CH2); δC (67.8 MHz, CDCl3) 214.4 (CO), 134.9
(CH), 116.7 (CH2), 70.9 (CH), 60.8 (CH), 51.4 (CH2), 43.5
(CH2), 32.7 (CH2), 30.9 (CH2), 25.4 (CH2), 24.4 (CH2); m/z (EI)
138.0912 (Mϩ Ϫ C3H5. C8H12NO requires 138.0919).
CH2CH2CO and 1 × CH2CO), 1.97 (1H, dt, J 11.5 and 2.6, 1 ×
CH2CO), 1.92–1.86 (1H, m, 1 × COCH2CH2), 1.80–1.27 (7H,
m, 1 × COCH2CH2, NCH2CH2, NCH2CH2CH2 and NCH2-
CH2CH2CH2); δC (67.8 MHz, CDCl3) 208.1 (CO), 135.5 (CH),
116.3 (CH2), 71.9 (CH), 60.5 (CH), 52.5 (CH2), 39.2 (CH2), 33.2
(CH2), 31.9 (CH2), 31.2 (CH2), 25.6 (CH2), 23.9 (CH2).
(3R*,8aS*)-3-Allylhexahydroindolizin-2(3H)-one 19b. Silica
gel (1.0 g) was added to a solution of the indolizidinone 19a
(23.9 mg, 0.133 mmol) in diethyl ether (10 cm3) and the mixture
was stirred at room temperature for 15 h. Further silica gel
(1.0 g) was added and the mixture was stirred at room temper-
ature for an additional 8 h period. The mixture was filtered and
the silica gel washed with further diethyl ether (3 × 15 cm3). The
combined solution and washings were concentrated in vacuo,
and the crude product purified by flash column chrom-
atography on silica gel (hexane–diethyl ether, 4 : 1) to give the
indolizidinone 19b (17.1 mg, 72%) as a colourless liquid.
(2R,3S,8S)-3-Allylhexahydropyrrolizidin-2-ol 22. Sodium
borohydride (8 mg, 0.2 mmol) was added to a solution of the
indolizidinone 18a (50 mg, 0.30 mmol) in methanol (2 cm3) and
the mixture was stirred for 4 h at room temperature. The solvent
was removed in vacuo and the residue washed with ethyl acetate.
The organic washings were filtered, concentrated in vacuo and
the residue washed with several portions of hexane to give the
alcohol 22 (45 mg, 89%) as a white solid; mp 61–62 ЊC [α]2D8 Ϫ1.7
(c 0.49, CHCl3); νmax(CHCl3)/cmϪ1 3619, 2962, 2871, 1639,
1000, 915; δH (500 MHz, CDCl3) 6.02–5.94 (1H, dddd, J 17.1,
10.1, 7.3 and 7.3, CH᎐CH ), 5.22 (1H, d, J 17.1, trans CH᎐
᎐
᎐
2
CH ), 5.12 (1H, d, J 10.1, cis CH᎐CH ), 4.14–4.04 (1H, m,
᎐
2
2
(5R,9S)-5-Allylhexahydroindolizin-6(5H)-one 20b. Accord-
ing to the general procedure, a solution of the α-diazo ketone 14
(0.10 g, 0.48 mmol) in dry benzene (50 cm3) was added to a
solution of Cu(acac)2 (2.5 mg, 0.0096 mmol) in dry benzene
(10 cm3) at reflux, over a period of 30 min. The resulting sol-
ution was stirred at reflux for a further 15 min. Purification by
flash column chromatography on silica gel (hexane–diethyl
ether, 2 : 1) gave the indolizidinone 20b (57 mg, 66%) as a colour-
less liquid; [α]2D4 Ϫ1.2 (c 0.98, CHCl3); νmax(film)/cmϪ1 2943,
2880, 2797, 2739, 1716, 1640, 995, 913; δH (500 MHz, CDCl3)
CHOH), 3.56–3.45 (1H, m, 1 × NCH2), 3.02 (1H, ddd, J 12.0,
6.0 and 4.5, 1 × NCH ), 2.73–2.68 (1H, m, 1 × CH CH᎐CH ),
᎐
2
2
2
2.54 (m, 1H, 1 × CH CH᎐CH ), 2.42–2.33 (3H, m, NCHCH ,
᎐
2
2
2
NCHCHOH and 1 × CH2CHOH), 2.02–1.76 (4H, m, 1 ×
CH2CHOH, NCH2CH2CH2 and OH), 1.59–1.47 (2H, m,
NCH2CH2); δC (67.8 MHz, CDCl3) 136.3 (CH), 116.9 (CH2),
77.8 (CH), 71.9 (CH), 61.1 (CH), 54.7 (CH2), 40.3 (CH2), 39.3
(CH2), 33.1 (CH2), 25.9 (CH2); m/z (EI) 167.1312 (Mϩ.
C10H17NO requires 167.1310), 167 (Mϩ, 0.2%), 126 (100)
(Found C, 71.7; H, 10.35; N, 8.4. C10H17NO requires C, 71.8;
H, 10.2; N, 8.4%).
5.93–5.84 (1H, m, CH᎐CH ), 5.12 (1H, br d, J 17.2, trans CH᎐
᎐
᎐
2
CH ), 5.04 (1H, br d, J 10.1, cis, CH᎐CH ), 3.29–3.23 (1H, m,
᎐
2
2
NCHCO), 2.83–2.78 (1H, m, NCHCH2CH2), 2.65–2.59 (1H,
m, 1 × NCH ), 2.57–2.46 (3H, m, 1 × NCH and CH CH᎐
Crystal structure determination of alcohol 22.‡ Crystal data.
C10H17NO, M = 167.25, monoclinic, a = 8.536(2), b = 11.150(3),
c = 10.547(2) Å, β = 105.40(2)Њ, U = 967.8(4) Å3, T = 150(2) K,
space group P21/c (No. 14), Z = 4, Dc = 1.148 g cmϪ3, µ(Mo-
Kα) = 0.073 mmϪ1, 1702 unique reflections (Rint = 0.092) col-
lected and used in all calculations. Final R1 [1258 F > 4σ(F)] =
0.0570 and wR(all F 2) was 0.141.
᎐
2
2
2
CH2), 2.40–2.31 (1H, m, 1 × CH2CO), 2.21–2.07 (2H, m,
1 × CH2CO and 1 × NCH2CH2CH2), 2.03–1.80 (3H, m, 1 ×
NCH2CH2CH2 and CH2CH2CO), 1.75–1.66 (1H, m, 1 ×
NCH2CH2), 1.56–1.47 (1H, m, 1 × NCH2CH2); δC (67.8 MHz,
CDCl3) 207.5 (CO), 135.5 (CH), 116.5 (CH2), 72.2 (CH), 62.9
3334
J. Chem. Soc., Perkin Trans. 1, 2001, 3325–3337